IL18 and ovarian cancer: Inhibition of fos‐like antigen 2 (FOSL2) limits ovarian cancer development through upregulation of proteins associated with inflammasome formation, including ASC, pro‐caspase 1, caspase 1, pro‐IL‐1, pro‐IL‐18, and IL‐18.220